Stocks such as Maruti Suzuki, Swan Energy, Emami, Hindalco, Vedanta, Tube Investments, MMTC, Cera Sanitaryware have touched their fresh 52-...

If you are reading this, chances are Sensex and Nifty are part of your daily life, and actions on Dalal Street can make or mar your day.

In this space, ETMarkets.com tracks the elite 30 from the Sensex pack, 50 from the nimble Nifty LIVE, the newsmakers and top market movers ...

Drug firm Claris Lifesciences today reported a 31.09 per cent rise in its consolidated net profit to Rs 20.28 crore for the quarter.

Stocks of Claris Lifesciences surged over 10% today amid reports that Cadila Healthcare has emerged as the front runner to acquire the gene...

Stocks of Claris Lifesciences climbed over 4% after one of its existing shareholders sold out its entire stake in the company via a block d...

The drug firm said it markets its products through a wholly-owned subsidiary Claris Lifesciences Inc.

Carlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...

Claris Lifesciences reported an over five-fold jump in its consolidated net profit at Rs 89.84 crore for the quarter ended December 31, 210...

The 50-share Nifty index closed below its crucial psychological level of 7900, weighed down by losses in metal, IT, pharma and realty stock...

"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."

Claris Lifesciences today reported a 29.50 per cent decline in consolidated net profit to Rs 17.75 crore for the quarter ended on December ...

Claris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.

Essar Oil is being moved out of the BSE's 100 index and would be replaced by Satyam Computer Services.

The approval will allow Claris to manufacture and sell its products in te US and also receive abbreviated new drug application approvals, t...